Faricimab at 6 and 12 mg reduces pigment epithelium detachment in treatment-resistant macular neovascularization: an OCT and AI analysis.

Sci Rep · 2025 · PMC12484819 · PMID 41028859

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although a numerical reduction was observed, it did not reach statistical significance across the first three injections or the follow-up period.

also in 111,027 other papers

showed a trendno p-value reported

OCTA showed a trend toward reduced vascular activity after switching to Faricimab 6 mg, but no further change with dose escalation.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.